Delivery Order SPE2DB20D9329-SPE2DB22FD4NL
Award Date 5/24/22
Potential Completion Date 5/25/22
Potential Value $3.4K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $6,393.26 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of 4,558,189,631 units of Naloxone HCL 4 mg nasal spray. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which covers a wide range of pharmaceutical products for military health facilities...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,840.00 contract is for the delivery of 4,557,523,711 units of Naloxone Hydrochloride 4 mg Nasal Spray. The award is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, valued at up to $499,999,999 and running...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of 4,557,954,905 units of Naloxone hydrochloride 4 mg nasal spray. The contract has a ceiling value of $5,266.28 and an ultimate completion date of August 2, 2022. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which covers a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Naloxone Hydrochloride, a medication used to treat opioid overdoses, with a ceiling value of $3,188.40 and a completion date of June 9, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation. DMS Pharmaceutical Group holds a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,092.12 firm fixed-price contract is for the delivery of naloxone 0.4 mg/ml vials, with a performance period ending on May 13, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of 4562900589 - NALOXONE 2 MG/2 ML SYRINGE 2ML. The contract has a ceiling value of $1,529.30 and a period of performance through November 28, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation, issued under a larger indefinite delivery contract (IDC) with DMS Pharmaceutical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The contract is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical opioid overdose reversal medication, to support the recurring medical supply needs of military health facilities worldwide. The contract has a ceiling value of $3,259.20 and is a firm fixed-price delivery order, with no...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,084.80 contract is for the delivery of 4,567,311,856 units of Naloxone HCl 4 mg Nasal Spray, a critical opioid overdose reversal medication, with a period of performance through February 20, 2025. This delivery order is placed under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract with the DLA,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,455.51 firm fixed-price delivery order is for the supply of 4548466516 - NALOXONE HCL SPRAY 2S, and has an ultimate completion date of December 20, 2019. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $1,434.00 and has a firm fixed price pricing type. The contract is for the supply of naloxone hydrochloride, a medication used to reverse opioid overdose. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group, valued at up to...